{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2022-07-21T09:48:38.000+02:00",
                "untilDate": "2024-06-10T17:38:27.000+02:00"
            }
        ],
        "firstPublicationDate": "2022-05-04T09:49:36.000+02:00",
        "inactiveDateRanges": [
            {
                "fromDate": "2024-06-10T17:38:27.000+02:00"
            }
        ],
        "lastUpdateDate": "2023-08-07T09:01:45.000+02:00",
        "registerEntryVersions": [
            {
                "activeUntilDate": "2024-06-10T17:38:27.000+02:00",
                "legislation": "GL2022",
                "registerEntryId": 10453,
                "validFromDate": "2023-08-07T09:01:45.000+02:00",
                "version": 3,
                "versionActiveLobbyist": false
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 10346,
                "validFromDate": "2022-07-21T09:48:38.000+02:00",
                "validUntilDate": "2023-08-07T09:01:45.000+02:00",
                "version": 2,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": false,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_ORGANIZATION",
            "de": "Unternehmen",
            "en": "Company"
        },
        "activityDescription": "Kommunikation mit einem Bundestagsabgeordneten zum Thema Forschungsf\u00f6rderung. Zum einen \u00fcber praktische und administrative Probleme des F\u00f6rderprogramms zur Entwicklung dringend ben\u00f6tigter Therapeutika gegen SARS-CoV-2 und zum anderen zur Verbesserung der Rahmenbedingungen der klinischen Forschung und Entwicklung, speziell in Deutschland als unverzichtbaren Standortfaktor f\u00fcr eine Schl\u00fcsselbranche.",
        "activityOperationType": "BOTH",
        "fieldsOfInterest": [
            {
                "code": "FOI_SCIENCE_RESEARCH_TECHNOLOGY",
                "de": "Wissenschaft, Forschung und Technologie",
                "en": "Science, research and technology"
            }
        ],
        "legislativeProjects": []
    },
    "annualReports": {
        "annualReportExists": true,
        "annualReportPdfUrl": "https://www.lobbyregister.bundestag.de/media/23/18/227064/Atriva-Offenlegung-Jahresabschluss-2022.pdf",
        "disclosureRequirementsExist": true,
        "reportWasPublishedElsewhere": false
    },
    "clientIdentity": {
        "clientsPresent": false
    },
    "codeOfConduct": {
        "ownCodeOfConduct": false
    },
    "donators": {
        "donatorsInformationPresent": false,
        "fiscalYearCompleted": true,
        "fiscalYearEnd": "2022-12",
        "fiscalYearStart": "2022-01",
        "refuseDonatorsInformation": false
    },
    "employeesInvolvedInLobbying": {
        "employeesCount": {
            "from": 1,
            "to": 10
        }
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 40001,
            "to": 50000
        },
        "fiscalYearCompleted": true,
        "fiscalYearEnd": "2022-12",
        "fiscalYearStart": "2022-01",
        "refuseFinancialExpensesInformation": false
    },
    "legislation": "GL2022",
    "lobbyistIdentity": {
        "address": {
            "city": "Planegg/Martinsried",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "street": "Am Klopferspitz",
            "streetNumber": "19",
            "type": "NATIONAL",
            "zipCode": "82152"
        },
        "contactDetails": {
            "emails": [
                {
                    "email": "info@atriva-therapeutics.com"
                }
            ],
            "phoneNumber": "+4969999916210",
            "websites": [
                {
                    "website": "www.atriva-therapeutics.com"
                }
            ]
        },
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_GMBH",
            "de": "Gesellschaft mit beschr\u00e4nkter Haftung (GmbH)",
            "en": "Limited liability company (GmbH)"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "academicDegreeBefore": "Dr. ",
                "commonFirstName": "Rainer",
                "emails": [
                    {
                        "email": "lichtenberger@atriva-therapeutics.com"
                    }
                ],
                "function": "Gesch\u00e4ftsf\u00fchrer",
                "lastName": "Lichtenberger",
                "phoneNumber": "+4969999916210"
            },
            {
                "commonFirstName": "Christian",
                "emails": [
                    {
                        "email": "pangratz@atriva-therapeutics.com"
                    }
                ],
                "function": "Gesch\u00e4ftsf\u00fchrer",
                "lastName": "Pangratz",
                "phoneNumber": "+4969999916210"
            }
        ],
        "membersPresent": false,
        "memberships": [
            {
                "membership": "Bundesverband der Pharmazeutischen Industrie e.V."
            },
            {
                "membership": "Bio Deutschland e.V."
            }
        ],
        "membershipsPresent": true,
        "name": "Atriva Therapeutics GmbH",
        "namedEmployeesPresent": false
    },
    "publicAllowances": {
        "fiscalYearCompleted": true,
        "fiscalYearEnd": "2022-12",
        "fiscalYearStart": "2022-01",
        "publicAllowances": [
            {
                "description": "Zuwendung aus dem Bundeshaushalt f\u00fcr das Vorhaben \"COVID19 Therapeutica\"",
                "location": "Berlin",
                "name": "Bundesministerium f\u00fcr Bildung und Forschung",
                "publicAllowanceEuro": {
                    "from": 6550001,
                    "to": 6560000
                }
            }
        ],
        "publicAllowancesPresent": true,
        "refusePublicAllowancesInformation": false
    },
    "registerEntryDetails": {
        "annualUpdate": {
            "lastAnnualUpdate": "2023-08-07T09:01:45.000+02:00",
            "updateMissing": false
        },
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R004431/10453",
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/05/d8/227065/Lobbyregister-Detailansicht-R004431-2023-08-07_09-01-45.pdf",
        "refusedAnything": false,
        "validFromDate": "2023-08-07T09:01:45.000+02:00",
        "version": 3
    },
    "registerEntryId": 10453,
    "registerNumber": "R004431"
}